Glenmark Life Sciences standalone net profit declines 7.22% in the September 2022 quarter
Sales decline 9.34% to Rs 509.30 crore
Net profit of Glenmark Life Sciences declined 7.22% to Rs 106.88 crore in the quarter ended September 2022 as against Rs 115.20 crore during the previous quarter ended September 2021. Sales declined 9.34% to Rs 509.30 crore in the quarter ended September 2022 as against Rs 561.76 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales509.30561.76 -9 OPM %28.2029.79 -PBDT153.53162.20 -5 PBT143.59152.53 -6 NP106.88115.20 -7Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 21 2022 | 2:53 PM IST